CYPROTEX/SYGNATURE PARTNERSHIP EXTENDED

Drug testing firm Cyprotex has extended its partnership with a Nottingham-based company by two years.

The AIM-listed business has made the further commitment to its “successful” strategic alliance with Sygnature Discovery.

Cyprotex, which employs 50 in Macclesfield, uses software to predict how well drugs will work and provides this service to the pharmaceutical sector.

It has worked with Sygnature to jointly sell and market each other`s offerings, so clients receive a “fully-integrated” service.

Cyprotex xhief executive Dr Anthony Baker said he was “delighted” to extend the partnership.